1. Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients
   Mamatha Bhat et al, 2023, Cancer Medicine CrossRef
2. Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?
   Mamatha Bhat et al, 2015, Clinical Transplantation CrossRef
3. Liver Transplantation for Other Cancers
   Sandra Garcia-Aroz et al, 2018, Primary and Metastatic Liver Tumors CrossRef
4. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients
   Mamatha Bhat et al, 2018, Mayo Clinic Proceedings CrossRef
5. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway
   Yi Wang et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
6. De novo malignancies after liver transplantation: The effect of immunosuppressionn-personal data and review of literature
   Tommaso Maria Manzia et al, 2019, World Journal of Gastroenterology CrossRef
7. Cancers solides après transplantation d’organe : épidémiologie, pronostic et spécificités de prise en charge
   Aude Guillemin et al, 2017, Bulletin du Cancer CrossRef